RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

Nchi: Australia

Lugha: Kiingereza

Chanzo: Department of Health (Therapeutic Goods Administration)

Viambatanisho vya kazi:

raloxifene hydrochloride, Quantity: 60 mg

Inapatikana kutoka:

MedTAS Pty Ltd

INN (Jina la Kimataifa):

Raloxifene hydrochloride

Dawa fomu:

Tablet, film coated

Tungo:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

Njia ya uendeshaji:

Oral

Vitengo katika mfuko:

28 tablets

Dawa ya aina:

(S4) Prescription Only Medicine

Matibabu dalili:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

Bidhaa muhtasari:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

Idhini hali ya:

Licence status A

Idhini ya tarehe:

2014-01-14